TY  - JOUR
T1  - MEthotrexate-associated, early-onset pancytopenia in rheumatoid arthritis
AU  - Doolittle GC, Simpson KM, Lindsley HB
Y1  - 1989/06/01
N1  - 10.1001/archinte.1989.00390060140032
JO  - Archives of Internal Medicine
SP  - 1430
EP  - 1431
VL  - 149
IS  - 6
N2  - • A patient with rheumatoid arthritis presented with pancytopenia 3 weeks after initiation of low-dose methotrexate administered orally. She had minimal renal insufficiency and hypoalbuminemia prior to initiation of methotrexate therapy, and had received a nonsteroidal anti-inflammatory drug concurrently. Bone marrow recovery occurred within 3 weeks. Patients receiving low-dose methotrexate therapy for rheumatoid arthritis require early monitoring for bone marrow injury, especially those who have risk factors for possible methotrexate toxicity.(Arch Intern Med. 1989;149:1430-1431)
SN  - 0003-9926
M3  - doi: 10.1001/archinte.1989.00390060140032
UR  - http://dx.doi.org/10.1001/archinte.1989.00390060140032
ER  -